�ֲ���ý

Utility and Safety of Back-Up Insulin Regimens Generated by the Bionic Pancreas: A Randomized Study.; Diabetes technology & therapeutics; (2023).

An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment; Journal of Pediatric Endocrinology and Metabolism; (2023).

Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review; Endocrine reviews; (2023).

A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes.; Diabetes technology & therapeutics; (2022).

RF30 | PSAT178 Severe Hyperparathyroidism in a Newborn: Response to Cinacalcet; Journal of the Endocrine Society; (2022).

Impact of dysglycemia and obesity on the brain in adolescents with and without type 2 diabetes: A pilot study.; Pediatric diabetes; (2022).

The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes; Diabetes Technology & Therapeutics; (2022).

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes; New England Journal of Medicine; (2022).

A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes; Nature Communications; (2022).

Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial; The Lancet Digital Health; (2022).

Genetic conditions of short stature: A review of three classic examples; Frontiers in Endocrinology; (2022).

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States; Frontiers in Pediatrics; (2022).

Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents; Diabetes, Obesity and Metabolism; (2022).

Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial; Diabetes Technology and Therapeutics; (2022).

Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study; Diabetes Care; (2021).

Erratum: Phase 3 Trial of a Small-Volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty (The Journal of Clinical Endocrinology and Metabolism (2020) 105:10 (e3660-e3671) DOI: 10.1210/clinem/dgaa479); Journal of Clinical Endocrinology and Metabolism; (2021).

Brain function differences in children with type 1 diabetes: A functional mri study of working memory; Diabetes; (2020).

Can Short Bouts of Exercise ("Exercise Snacks") Improve Body Composition in Adolescents with Type 1 Diabetes? A Feasibility Study; Hormone Research in Paediatrics; (2020).

Estrogen replacement in turner syndrome; Turner Syndrome: Pathophysiology, Diagnosis and Treatment; (2020).

Phase 3 trial of a small-volume subcutaneous 6-month duration leuprolide acetate treatment for central precocious puberty; Journal of Clinical Endocrinology and Metabolism; (2020).

Glutamine and type 1 diabetes mellitus: is there a role in glycemic control?; Current Opinion in Clinical Nutrition and Metabolic Care; (2019).

Executive task-based brain function in children with type 1 diabetes: An observational study; PLoS Medicine; (2019).

Impact of early diabetic ketoacidosis on the developing brain; Diabetes Care; (2019).

Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome; Clinical Endocrinology; (2019).

Psychometric performance of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire in a randomized open-label comparator trial in idiopathic short stature; Journal of Pediatric Endocrinology and Metabolism; (2019).

Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors; Hormone Research in Paediatrics; (2019).

Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations; Journal of Clinical Endocrinology and Metabolism; (2018).

Is There a Difference between Ultrasonographic (US) Uterine Changes of Oral Versus Transdermal (TD) 17β Estradiol (17β E2) in Girls with Turner Syndrome (TS)? Own Experience and Literature Review; Pediatric endocrinology reviews : PER; (2018).

Longitudinal assessment of hippocampus structure in children with type 1 diabetes; Pediatric Diabetes; (2018).

Persistence of abnormalities in white matter in children with type 1 diabetes; Diabetologia; (2018).

Interventions to reduce cardiovascular risk in children with type 1 diabetes; Current Diabetes Reviews; (2017).

Does oral glutamine improve insulin sensitivity in adolescents with type 1 diabetes?; Nutrition; (2017).

Clinical practice guidelines for the care of girls and women with Turner syndrome: Proceedings from the 2016 Cincinnati International Turner Syndrome Meeting; European Journal of Endocrinology; (2017).

Compensatory Hyperconnectivity in Developing Brains of Young Children With Type 1 Diabetes; Diabetes; (2016).

Altered Integration of Structural Covariance Networks in Young Children With Type 1 Diabetes; Human Brain Mapping; (2016).

Safety of using real-time sensor glucose values for treatment decisions in adolescents with poorly controlled type 1 diabetes mellitus: a pilot study; Pediatric Diabetes; (2016).

Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months; Journal of the International Neuropsychological Society; (2016).

Erratum: Estrogens and their genotoxic metabolites are increased in obese prepubertal girls (J Clin Endocrinol Metab (2015) 100:6 (2322-2328) DOI: 10.1210/jc.2015-1495); Journal of Clinical Endocrinology and Metabolism; (2016).

Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature; The Journal of Clinical Endocrinology & Metabolism; (2016).

Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes; Diabetes; (2015).

Estrogens and Their Genotoxic Metabolites Are Increased in Obese Prepubertal Girls; The Journal of Clinical Endocrinology & Metabolism; (2015).

Evaluation of the American-English Quality of Life in Short Stature Youth (QoLISSY) questionnaire in the United States; Health and Quality of Life Outcomes; (2015).

Commentary: Launch of a Quality Improvement Network for Evidence-Based Management of Uncommon Pediatric Endocrine Disorders: Turner Syndrome as a Prototype; The Journal of Clinical Endocrinology & Metabolism; (2015).

Proceedings from the Turner Resource Network symposium: The crossroads of health care research and health care delivery; American Journal of Medical Genetics, Part A; (2015).

Cognitive Functioning in Young Children with Type 1 Diabetes; Journal of the International Neuropsychological Society; (2014).

High success rates of sedation-free brain MRI scanning in young children using simple subject preparation protocols with and without a commercial mock scanner-the Diabetes Research in Children Network (DirecNet) experience; Pediatric Radiology; (2014).

Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children With Type 1 Diabetes: Association With Hyperglycemia; Diabetes; (2014).

Magnetic resonance imaging measures of decreased aortic strain and distensibility are proportionate to insulin resistance in adolescents with type 1 diabetes mellitus; Pediatric Diabetes; (2014).

Persistently high glucose levels in young children with type 1 diabetes; Pediatric Diabetes; (2014).

Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis.; Diabetes care; (2014).

Skin and Adhesive Issues With Continuous Glucose Monitors; Journal of Diabetes Science and Technology; (2014).

36-Month Treatment Experience of Two Doses of Leuprolide Acetate 3-Month Depot for Children With Central Precocious Puberty; The Journal of Clinical Endocrinology & Metabolism; (2014).

A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes; Pediatric Diabetes; (2014).

Neuroanatomical Correlates of Dysglycemia in Young Children With Type 1 Diabetes; Diabetes; (2013).

Metabolic Effects of Oral Versus Transdermal 17β-Estradiol (E2): A Randomized Clinical Trial in Girls With Turner Syndrome; The Journal of Clinical Endocrinology & Metabolism; (2013).

Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years; Diabetes Care; (2013).

Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes.; Diabetes care; (2013).

Alterations in White Matter Structure in Young Children With Type 1 Diabetes; Diabetes Care; (2013).

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism; Nature Genetics; (2013).

Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus; Pediatric Diabetes; (2013).

Lifestyle Intervention Improves Fitness Independent of Metformin in Obese Adolescents; Medicine & Science in Sports & Exercise; (2012).

The T1D Exchange clinic registry.; The Journal of clinical endocrinology and metabolism; (2012).

Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious Puberty; The Journal of Clinical Endocrinology & Metabolism; (2012).

Continuous glucose monitoring in type 1 diabetes; Endocrine; (2012).

Lipoprotein Subfractions by Ion Mobility in Lean and Obese Children; The Journal of Pediatrics; (2012).

Estrogen therapy in Turner syndrome: Does the type, dose and mode of delivery matter?; Pediatric Endocrinology Reviews; (2012).

Acute changes in blood glucose do not alter blood glutathione synthesis in adolescents with poorly controlled type 1 diabetes mellitus; Metabolism; (2012).

Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual  -Cell Function; Diabetes Care; (2012).

Metformin use in children with obesity and normal glucose tolerance – effects on cardiovascular markers and intrahepatic fat; Journal of Pediatric Endocrinology and Metabolism; (2012).

Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes; Pediatric Diabetes; (2012).

The landmark JDRF continuous glucose monitoring randomized trials: A look back at the accumulated evidence; Journal of Cardiovascular Translational Research; (2012).

The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring; Pediatric Diabetes; (2011).

Pharmacokinetics and Pharmacodynamics of Oral and Transdermal 17β Estradiol in Girls with Turner Syndrome; The Journal of Clinical Endocrinology & Metabolism; (2011).

Health utilities for children and adults with type 1 diabetes.; Medical care; (2011).

Strategies for Maximizing Growth in Puberty in Children with Short Stature; Pediatric Clinics of North America; (2011).

Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes.; Diabetic medicine : a journal of the British Diabetic Association; (2011).

Persistence of Individual Variations in Glycated Hemoglobin: Analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial; Diabetes Care; (2011).

Factors predictive of severe hypoglycemia in type 1 diabetes: Analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset; Diabetes Care; (2011).

A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years; Diabetes Care; (2011).

Effects of Growth Hormone and Nutritional Therapy in Boys with Constitutional Growth Delay: A Randomized Controlled Trial; The Journal of Pediatrics; (2011).

Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.; Diabetes care; (2011).

Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.; Diabetes technology & therapeutics; (2011).

OR11,65 Randomized controlled trial on the effects of growth hormone therapy and nutritional supplementation in boys with constitutional growth delay; Growth Hormone & IGF Research; (2010).

Effects of Glutamine on Glycemic Control During and After Exercise in Adolescents With Type 1 Diabetes: A pilot study; Diabetes Care; (2010).

Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring.; Diabetes technology & therapeutics; (2010).

Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial; Diabetes Care; (2010).

Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial.; Diabetes care; (2010).

Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.; Diabetes technology & therapeutics; (2010).

Obesity without Established Comorbidities of the Metabolic Syndrome Is Associated with a Proinflammatory and Prothrombotic State, Even before the Onset of Puberty in Children; The Journal of Clinical Endocrinology & Metabolism; (2010).

The cost-effectiveness of continuous glucose monitoring in type 1 diabetes.; Diabetes care; (2010).

Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals.; Diabetes care; (2010).

Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT); Journal of Pediatric Endocrinology and Metabolism; (2010).

PP415 EFFECT OF ACUTE CHANGES IN BLOOD GLUCOSE ON GLUTATHIONE METABOLISM IN ADOLESCENTS WITH TYPE 1 DIABETES; Clinical Nutrition Supplements; (2010).

GH Use in the Transition of Adolescence to Adulthood; Current Indications for Growth Hormone Therapy; (2010).

Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes; Diabetes Care; (2010).

Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes; Diabetes Care; (2009).

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.; Diabetes care; (2009).

Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes.; Diabetes care; (2009).

Pharmacokinetics and Pharmacodynamics of Anastrozole in Pubertal Boys with Recent-Onset Gynecomastia; The Journal of Clinical Endocrinology & Metabolism; (2009).

Erratum to “Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures” [Steroids 2008;73(13):1318-21]; Steroids; (2009).

Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.; The Journal of clinical endocrinology and metabolism; (2009).

Can Growth Hormone Counteract the Catabolic Effects of Steroids?; Hormone Research; (2009).

Juvenile diabetes research foundation continuous glucose monitoring study group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes (Diabetes Care (2009) 32, (1378-1383)); Diabetes Care; (2009).

Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures; Steroids; (2008).

Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: Results of an open-label, multicenter trial in the United States; Journal of Pediatric Endocrinology and Metabolism; (2008).

Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.; Pediatric diabetes; (2008).

JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods.; Diabetes technology & therapeutics; (2008).

Low-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes.; Pediatric diabetes; (2008).

Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated With Growth Hormone: A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years; Obstetrical & Gynecological Survey; (2008).

Adiponectin and catecholamine concentrations during acute exercise in children with type 1 diabetes; Pediatric Diabetes; (2008).

Poorly controlled type 1 diabetes is associated with altered glutathione homeostasis in adolescents: apparent resistance toN-acetylcysteine supplementation; Pediatric Diabetes; (2008).

Continuous glucose monitoring and intensive treatment of type 1 diabetes; New England Journal of Medicine; (2008).

Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children; Journal of Thrombosis and Haemostasis; (2008).

The accuracy of the Guardian® RT continuous glucose monitor in children with type 1 diabetes; Diabetes Technology and Therapeutics; (2008).

Corticosteroids increase glutamine utilization in human splanchnic bed; American Journal of Physiology - Gastrointestinal and Liver Physiology; (2008).

P018 Les corticoïdes augmentent l'utilisation splanchnique de la glutamine chez l'homme; Nutrition Clinique et Métabolisme; (2007).

Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors.; Diabetes care; (2007).

Metabolic Effects of OralVersusTransdermal Estrogen in Growth Hormone-Treated Girls with Turner Syndrome; The Journal of Clinical Endocrinology & Metabolism; (2007).

Relative accuracy of the BD Logic and FreeStyle blood glucose meters.; Diabetes technology & therapeutics; (2007).

Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans; Clinical Nutrition; (2007).

Randomized Trial of Behavioral Family Systems Therapy for Diabetes: Maintenance of effects on diabetes outcomes in adolescents; Diabetes Care; (2007).

Growth Hormone and Testosterone: Effects on Whole Body Metabolism and Skeletal Muscle in Adolescence; Hormone Research in Paediatrics; (2007).

Relative inaccuracy of the A1cNow in children with type 1 diabetes.; Diabetes care; (2007).

FreeStyle Navigator Continuous Glucose Monitoring System Use in Children With Type 1 Diabetes Using Glargine-Based Multiple Daily Dose Regimens: Results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group; Diabetes Care; (2007).

Continuous glucose monitoring in children with type 1 diabetes.; The Journal of pediatrics; (2007).

Amino-Terminal Propeptide of C-Type Natriuretic Peptide and Linear Growth in Children: Effects of Puberty, Testosterone, and Growth Hormone; The Journal of Clinical Endocrinology & Metabolism; (2007).

Growth hormone action in puberty: Effects by gender; Growth Hormone & IGF Research; (2007).

Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes; Pediatric Diabetes; (2007).

The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes; Diabetes Care; (2007).

Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin; Diabetes Care; (2006).

Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes; Pediatric Diabetes; (2006).

Self-care autonomy and outcomes of intensive therapy or usual care in youth with type 1 diabetes; Journal of Pediatric Psychology; (2006).

The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes; Diabetes Care; (2006).

Effects of behavioral family systems therapy for diabetes on adolescents' family relationships, treatment adherence, and metabolic control; Journal of Pediatric Psychology; (2006).

Evaluation of factors affecting CGMS calibration.; Diabetes technology & therapeutics; (2006).

Evidence for Hypermetabolism in Boys with Constitutional Delay of Growth and Maturation; The Journal of Clinical Endocrinology & Metabolism; (2006).

Use of Stable Isotopes to Assess Protein and Amino Acid Metabolism in Children and Adolescents: A Brief Review; Hormone Research in Paediatrics; (2006).

Preface; Hormone Research; (2006).

Influence of sex and β2 adrenergic receptor haplotype on resting and terbutaline-stimulated whole body lipolysis; Metabolism; (2005).

Limited Efficacy of Growth Hormone (GH) during Transition of GH-Deficient Patients from Adolescence to Adulthood: A Phase III Multicenter, Double-Blind, Randomized Two-Year Trial; The Journal of Clinical Endocrinology & Metabolism; (2005).

Sperm analysis in growth hormone-deficient adolescents previously treated with an aromatase inhibitor: Comparison with normal controls; Fertility and Sterility; (2005).

Response to nocturnal alarms using a real-time glucose sensor.; Diabetes technology & therapeutics; (2005).

A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes.; Diabetes care; (2005).

A Randomized Controlled Trial of Insulin Pump Therapy in Young Children With Type 1 Diabetes; Diabetes Care; (2005).

Treatment of adolescents with gynecomastia; The Journal of Pediatrics; (2005).

Diabetes self-management profile for flexible insulin regimens: cross-sectional and longitudinal analysis of psychometric properties in a pediatric sample.; Diabetes care; (2005).

Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.; Diabetes technology & therapeutics; (2005).

Function of the GlucoWatch G2 Biographer during exercise.; Diabetes technology & therapeutics; (2005).

Are the metabolic effects of GH and IGF-I separable?; Growth Hormone & IGF Research; (2005).

Endocrine Control of Body Composition in Infancy, Childhood, and Puberty; Endocrine Reviews; (2005).

Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus.; The Journal of pediatrics; (2005).

Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes.; Diabetes care; (2005).

Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors.; Diabetes technology & therapeutics; (2005).

Treatment of adolescents with gynecomastia [1] (multiple letters); Journal of Pediatrics; (2005).

Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study.; Diabetes technology & therapeutics; (2005).

Salutary Effects of Combining Early Very Low-Dose Systemic Estradiol with Growth Hormone Therapy in Girls with Turner Syndrome; The Journal of Clinical Endocrinology & Metabolism; (2005).

Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: Results of a Diabetes Research in Children Network (DirecNet) Study; Pediatric Diabetes; (2005).

Growth Hormone Therapy in the Glucocorticosteroid-Dependent Child: Metabolic and Linear Growth Effects; Hormone Research in Paediatrics; (2004).

Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: Results of the Diabetes Research in Children Network (DIRECNET) accuracy study; Journal of Pediatrics; (2004).

Erratum: Pharmacokinetics and Dose Finding of a Potent Aromatase Inhibitor, Aromasin (Exemestane), in Young Males (The Journal of Clinical Endocrinology &amp; Metabolism 88 (5951-5956)); Journal of Clinical Endocrinology and Metabolism; (2004).

GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children.; Diabetes technology & therapeutics; (2004).

History of domestic violence and health service use among mid-aged Australian women.; Australian and New Zealand journal of public health; (2004).

Can Glutamine and Growth Hormone Promote Protein Anabolism in Children with Cystic Fibrosis?; Hormone Research in Paediatrics; (2004).

Effects of Glutamine and Recombinant Human Growth Hormone on Protein Metabolism in Prepubertal Children with Cystic Fibrosis; The Journal of Clinical Endocrinology & Metabolism; (2004).

An Open Label 12-Month Pilot Trial on the Effects of the Aromatase Inhibitor Anastrozole in Growth Hormone (GH)-Treated GH Deficient Adolescent Boys; Journal of Pediatric Endocrinology and Metabolism; (2004).

Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network.; Diabetes care; (2004).

Evidence for Accelerated Rates of Glutathione Utilization and Glutathione Depletion in Adolescents With Poorly Controlled Type 1 Diabetes; Diabetes; (2004).

Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys; Metabolism; (2003).

Self-Management Competence as a Predictor of Outcomes of Intensive Therapy or Usual Care in Youth With Type 1 Diabetes; Diabetes Care; (2003).

Absence of Adverse Effects of Severe Hypoglycemia on Cognitive Function in School-Aged Children With Diabetes Over 18 Months; Diabetes Care; (2003).

Pharmacokinetics and Dose Finding of a Potent Aromatase Inhibitor, Aromasin (Exemestane), in Young Males; The Journal of Clinical Endocrinology & Metabolism; (2003).

The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study.; Diabetes technology & therapeutics; (2003).

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: A pilot study; Metabolism; (2002).

Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents; American Journal of Physiology - Endocrinology And Metabolism; (2001).

Recombinant Human Growth Hormone and Recombinant Human Insulin-Like Growth Factor I Diminish the Catabolic Effects of Hypogonadism in Man: Metabolic and Molecular Effects1; The Journal of Clinical Endocrinology & Metabolism; (2001).

GROWTH HORMONE AND SEX STEROIDS; Endocrinology and Metabolism Clinics of North America; (2001).

Growth Hormone Testing and the Short Child; Pediatric Research; (2001).

Author's Response: Aromatase Inhibitors in Pubertal Boys—Clinical Implications; The Journal of Clinical Endocrinology & Metabolism; (2001).

Aromatase inhibitors in pubertal boys: Clinical implications [3] (multiple letters); Journal of Clinical Endocrinology and Metabolism; (2001).

Erratum: Growth hormone and sex steroids: Interactions in puberty (Endocrinology and Metabolism Clinics of North America (September 2001)30:3(529, 535, 537)); Endocrinology and Metabolism Clinics of North America; (2001).

Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: Metabolic and molecular effects; Journal of Clinical Endocrinology and Metabolism; (2001).

Estrogen Treatment and Estrogen Suppression: Metabolic Effects in Adolescence; Journal of Pediatric Endocrinology and Metabolism; (2000).

Growth Hormone Stimulation Testing in Both Short and Normal Statured Children: Use of an Immunofunctional Assay; Pediatric Research; (2000).

High Dose Recombinant Human Growth Hormone (GH) Treatment of GH-Deficient Patients in Puberty Increases Near-Final Height: A Randomized, Multicenter Trial; Journal of Clinical Endocrinology &amp; Metabolism; (2000).

High Dose Recombinant Human Growth Hormone (GH) Treatment of GH-Deficient Patients in Puberty Increases Near-Final Height: A Randomized, Multicenter Trial1; The Journal of Clinical Endocrinology & Metabolism; (2000).

Recombinant Human Insulin-Like Growth Factor I Has Significant Anabolic Effects in Adults with Growth Hormone Receptor Deficiency: Studies on Protein, Glucose, and Lipid Metabolism; Journal of Clinical Endocrinology &amp; Metabolism; (2000).

Validation of a structured interview for the assessment of diabetes self-management.; Diabetes Care; (2000).

Insulin-Like Growth Factor I and Growth Hormone (GH) Treatment in GH-Deficient Humans: Differential Effects on Protein, Glucose, Lipid, and Calcium Metabolism; Journal of Clinical Endocrinology &amp; Metabolism; (2000).

Growth Hormone Therapy in Adults and Children; New England Journal of Medicine; (2000).

Recombinant Human Insulin-Like Growth Factor I Has Significant Anabolic Effects in Adults with Growth Hormone Receptor Deficiency: Studies on Protein, Glucose, and Lipid Metabolism1; The Journal of Clinical Endocrinology & Metabolism; (2000).

Estrogen Suppression in Males: Metabolic Effects1; The Journal of Clinical Endocrinology & Metabolism; (2000).

Insulin-Like Growth Factor I and Growth Hormone (GH) Treatment in GH-Deficient Humans: Differential Effects on Protein, Glucose, Lipid, and Calcium Metabolism1; The Journal of Clinical Endocrinology & Metabolism; (2000).

Is glutamine a ‘conditionally essential' amino acid in Duchenne muscular dystrophy?; Clinical Nutrition; (1999).

Pharmacokinetics of insulin-like growth factor I in hypopituitarism: correlation with binding proteins; American Journal of Physiology-Endocrinology and Metabolism; (1999).

Profound Hypogonadism Has Significant Negative Effects on Calcium Balance in Males: A Calcium Kinetic Study; Journal of Bone and Mineral Research; (1999).

Estrogen Suppression in Males: Metabolic Effects; Pediatric Research; (1999).

Metabolic Effects of GH/IGF-I, Testosterone, and Estrogen: Studies in Children and Adults; Sex-Steroid Interactions with Growth Hormone; (1999).

Growth hormone, insulin-like growth factor I and sex hormones: Effects on protein and calcium metabolism; Acta Paediatrica, International Journal of Paediatrics, Supplement; (1999).

Effects of High Dose rhGH Therapy in Adolescent Children with GH Deficiency: A Randomized, Multicenter Study • 460; Pediatric Research; (1998).

Optimizing estrogen replacement treatment in Turner syndrome; Pediatrics; (1998).

Additive Effects of GH and Testosterone on the Anabolic Changes of Puberty: A Metabolic Study † 459; Pediatric Research; (1998).

An immunofunctional GH assay: Use in children; Growth Hormone & IGF Research; (1998).

Ovarian Hyperandrogenism Is Associated with Insulin Resistance to Both Peripheral Carbohydrate and Whole-Body Protein Metabolism in Postpubertal Young Females: A Metabolic Study; Journal of Clinical Endocrinology & Metabolism; (1998).

Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity; Journal of Clinical Endocrinology & Metabolism; (1998).

Ovarian Hyperandrogenism Is Associated with Insulin Resistance to Both Peripheral Carbohydrate and Whole-Body Protein Metabolism in Postpubertal Young Females: A Metabolic Study1; The Journal of Clinical Endocrinology & Metabolism; (1998).

Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity1; The Journal of Clinical Endocrinology & Metabolism; (1998).

Partial growth-hormone insensitivity: The role of growth-hormone receptor mutations in idiopathic stature; Journal of Pediatrics; (1997).

Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with turner's syndrome: A calcium kinetic study; Metabolism; (1997).

Growth hormone, IGF-I and growth. New views of old concepts. Modern endocrinology and diabetes series, volume 4 By Thomas J. Merimee and Zvi Laron. London, Freund, 1996, $130 (266 pages), ISBN 965-294-092-5; Trends in Endocrinology and Metabolism; (1997).

rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery; American Journal of Physiology-Endocrinology and Metabolism; (1997).

Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth homone)-insulin- like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement; Journal of Clinical Endocrinology and Metabolism; (1997).

O-015. rhIGF-I: Differential sensitivity to SQ bolus vs continuous delivery; Endocrinology and Metabolism, Supplement; (1997).

Estrogen and Testosterone, But Not a Nonaromatizable Androgen, Direct Network Integration of the Hypothalamo-Somatotrope (Growth Hormone)-Insulin-Like Growth Factor I Axis in the Human: Evidence from Pubertal Pathophysiology and Sex-Steroid Hormone Replacement1; The Journal of Clinical Endocrinology & Metabolism; (1997).

Sex Steroids, Growth Hormone, Insulin-Like Growth Factor-1: Neuroendocrine and Metabolic Regulation in Puberty; Hormone Research; (1996).

P.39 Glutamine and leucine metabolism in Duchennemuscular dystrophy; Clinical Nutrition; (1996).

Effects of estrogen therapy on whole body proteins.; The Journal of Clinical Endocrinology & Metabolism; (1996).

The Rationale for the Use of Recombinant Human Growth Hormone and Insulin-Like Growth Factor-I for Catabolic Conditions in Humans; Hormone Research; (1996).

Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans; Journal of Clinical Endocrinology &amp; Metabolism; (1996).

Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone; Pediatric Nephrology; (1996).

Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.; The Journal of Clinical Endocrinology & Metabolism; (1996).

IGF-I Deficiency and Growth Failure: Association with Mutations in the Intracellular Domain of the Growth Hormone Receptor Gene. ▴ 541; Pediatric Research; (1996).

Effects of estrogen therapy on whole body proteins; Journal of Clinical Endocrinology & Metabolism; (1996).

Estrogens do not affect whole-body protein metabolism in the prepubertal female.; The Journal of Clinical Endocrinology & Metabolism; (1995).

Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.; The Journal of Clinical Endocrinology & Metabolism; (1995).

Glucocorticoids and growth problems; Acta Paediatrica; (1995).

Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.; The Journal of Clinical Endocrinology & Metabolism; (1995).

Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone.; Journal of Clinical Investigation; (1994).

Growth hormone-binding protein levels: Studies of children with short stature; Metabolism; (1994).

Effect of Human Growth Hormone and Insulin-Like Growth Factor I on Whole-Body Leucine and Estimates of Protein Metabolism; Hormone Research; (1993).

Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.; The Journal of Clinical Endocrinology & Metabolism; (1992).

Human Growth Hormone but Not Insulin-Like Growth Factor I Positively Affects Whole-Body Estimates of Protein Metabolism; Hormone Research; (1992).

Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: Evidence for defective target organ responsiveness in the Mauriac syndrome; Metabolism; (1991).

Estrogenic Modulation of the Gonadotropin-Releasing Hormone-Stimulated Secretory Activity of the Gonadotrope and Lactotrope in Prepubertal Females with Turner's Syndrome*; The Journal of Clinical Endocrinology & Metabolism; (1991).

Increased hGH Production Rate after Low-Dose Estrogen Therapy in Prepubertal Girls with Turner's Syndrome; Pediatric Research; (1990).

Androgen-dependent somatotroph function in a hypogonadal adolescent male: Evidence for control of exogenous androgens on growth hormone release; Metabolism; (1989).

Specific, Time-Dependent Actions of Low-Dose Ethinyl Estradiol Administration on the Episodic Release of Growth Hormone, Follicle-Stimulating Hormone, and Luteinizing Hormone in Prepubertal Girls with Turner's Syndrome *; The Journal of Clinical Endocrinology & Metabolism; (1989).

Changes in growth hormone (GH) secretion and in growth during puberty; Journal of Endocrinological Investigation; (1989).

Growth hormone secretion in puberty; Control of the onset of puberty III: proceedings of the 3rd International Conference of the control of the onset of puberty. ICS861; (1989).

Changes in growth hormone (GH) secretion and in growth during puberty.; Journal of endocrinological investigation; (1989).

Neuroendocrine Function in Survivors of Childhood Acute Lymphocytic Leukemia and Non-Hodgkins Lymphoma; Journal of Pediatric Hematology/Oncology; (1988).

Augmentation of Growth Hormone Secretion during Puberty: Evidence for a Pulse Amplitude-Modulated Phenomenon*; The Journal of Clinical Endocrinology & Metabolism; (1987).

Appraising the Instantaneous Secretory Rates of Luteinizing Hormone and Testosterone in Response to Selective Mu Opiate Receptor Blockade in Late Pubertal Boys; Journal of Andrology; (1987).

Selective β1-adrenergic receptor-blockade with atenolol enhances growth hormone releasing hormone and mediated growth hormone release in man; Metabolism; (1987).

Role of Endogenous Opiates in Pubertal Maturation: Opposing Actions of Naltrexone in Prepubertal and Late Pubertal Boys*; The Journal of Clinical Endocrinology & Metabolism; (1986).

Appraising Endocrine Pulse Signals at Low Circulating Hormone Concentrations: Use of Regional Coefficients of Variation in the Experimental Series To Analyze Pulsatile Luteinizing Hormone Release; Pediatric Research; (1986).

Failure to Detect the “Dawn Phenomenon” in Nondiabetic Subjects with Markedly Different Patterns of Nocturnal Growth Hormone Secretion*; The Journal of Clinical Endocrinology & Metabolism; (1986).

The McCune-Albright syndrome; European Journal of Endocrinology; (1986).

Hashimoto thyroiditis associated with thyroid cancer in adolescent patients; The Journal of Pediatrics; (1985).

Positive Impact of FreeStyle NavigatorTM Continuous Glucose Monitoring System Use in Children with Type 1; Unknown Source; (0000).

The Insulin-Only Bionic Pancreas Improves Glycemic Control in Non-Hispanic Whites and Minority Adults and Children with Type 1 Diabetes; Unknown Source; (0000).